Pictet Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Pictet Asset Management’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9M	Buy	289,458 +28,077	+11%	+$1.02M	0.01%	649
2026 Q1	$7.55M	Buy	261,381 +246,399	+1,645%	+$8.14M	0.01%	707
2025 Q4	$538K	Sell	14,982 -190,481	-93%	-$5.82M	﹤0.01%	1404
2025 Q3	$4.95M	Buy	205,463 +190,008	+1,229%	+$3.98M	﹤0.01%	792
2025 Q2	$230K	Buy	15,455 +1,327	+9%	+$15.5K	﹤0.01%	1767
2025 Q1	$132K	Hold	14,128	–	–	﹤0.01%	1878
2024 Q4	$181K	Hold	14,128	–	–	﹤0.01%	1875
2024 Q3	$140K	Hold	14,128	–	–	﹤0.01%	1905
2024 Q2	$221K	Hold	14,128	–	–	﹤0.01%	1708
2024 Q1	$302K	Buy	+14,128	New	+$265K	﹤0.01%	1539

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management's INDV Position: Q2 2026 in Review

Pictet Asset Management increased its Indivior Pharmaceuticals (INDV) stake by 11% in Q2 2026, buying an estimated $1.02M and bringing the position to 289,458 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #649.

Pictet Asset Management first reported a position in INDV in Q1 2024 and has held it in 10 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Pictet Asset Management held 289,458 shares of Indivior Pharmaceuticals worth $11.9M as of Q2 2026.
Pictet Asset Management bought 28,077 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.02M.
Indivior Pharmaceuticals made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #649 holding.
Pictet Asset Management first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.